학술논문
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure
Document Type
Article
Author
Packer, Milton; McMurray, John J.V.; Krum, Henry; Kiowski, Wolfgang; Massie, Barry M.; Caspi, Avi; Pratt, Craig M.; Petrie, Mark C.; DeMets, David; Kobrin, Isaac; Roux, Sebastien; Swedberg, Karl; Packer, Milton; Caspi, Avi; Kiowski, Wolfgang; Krum, Henry; Pratt, Craig; Swedberg, Karl; Massie, Barry; McMurray, John; McMurray, John; Connally, Eugene; Petrie, Mark; DeMets, David; Anderson, Susan; Barnet, Jody; Cody, Robert; Dargie, Henry; Francis, Gary; Greenberg, Barry; Reichen, Juerg; Karrasch, J.; Krum, H.; Horowitz, J.; Amerena, J.; Sindone, A.; MacDonald, P.; Jeffrey, I.; Button, I.; DeAngelis, E.; Pacher, R.; Davies, R.; McAlister, F.; Tanser, P.; Sussex, B.; Baumann, G.; Fleck, E.; Olbrich, H.-G.; Werdan, K.; Klein, H.; Staffeld, F.; Zeiher, A.M.; Roediger, C.; Caspi, A.; Marmor, A.; Reisin, L.; Vered, Z.; Klainman, E.; Roguin, N.; Tzivoni, D.; David, D.; Lewis, B.; Abinader, E.; Omary, M.; Rosenman, Y.; Kaluski, E.; Breedveld, R.W.; van der Burgh, P.H.; Dunselman, P.H.J.M.; Schaafsma, H.J.; Hertzberger, D.P.; Holwerda, N.J.; Kragten, J.A.; van Wijngaarden, J.; Posma, J.L.; Said, S.A.M.; Slegers, L.C.; Tjon Joe Gin, R.M.; Wempe, F.N.; Wesdorp, J.C.L.; Willems, A.R.; Withagen, A.J.A.M.; Cornel, J.M.; van Kempen, L.H.J.; Kiowski, W.; Bertel, O.; Moccetti, T.; McMurray, J.J.V.; Greenbaum, R.A.; Bennett, P.; Swan, J.; Davies, G.; Findlay, I.; Gould, B.; Ball, S.; Hubner, P.; Lahiri, A.; McLay, J.; Northcote, R.; Saltissi, S.; Squire, I.; Stephens, J.; Stewart, M.; Bridgen, G.; Walsh, J.; Webb, D.J.; Ansari, Z.; Baron, S.; Bellinger, R.; Bennet, W.; Benvenuti, D.; Dawley, D.; Egbujiobi, L.C.; Eisenstein, I.; Little, T.; Hertsberg, A.; Greenspan, M.; Grossman, R.J.; Hanley, P.; Jesrani, M.; Kashou, H.; Levites, R.; Malik, R.; Marmorstein, B.; Schwartz, M.; Nisar, A.; Perelman, R.; Schwarz, M.L.; Sedlis, S.; Srebro, J.; Taveras, M.; Weiss, R.; Weitzman, P.; Wetherley, G.K.; El Shahawy, M.; Kereiakes, D.; Campos, L.; Peterson, G.; Small, R.S.; Davis, W.R.; Olivari, M.-T.; Meengs, W.; Koren, M.; Slagona, P.; Jennison, S.; Hershberger, R.; Browne, K.F.; Farnham, D.J.; Zelenkofske, S.; Lawless, C.; Nathan, M.; Meyer, T.; Kukin, M.; Parekh, H.; Berkowitz, R.; Boehmer, J.; Brozena, S.; Dandona, P.; Dec, G.W.; DeQuattro, V.; Fenster, P.; Fowler, M.; Ellaham, S.; Geller, M.; Gheorgiade, M.; Ghali, J.; Murali, S.; Katz, S.; Bott-Silverman, C.; Singh, B.; Thadani, U.; Torre, G.; Teerlink, J.; Chandraratna, T.; Kesselbrenner, M.; Mukherjee, A.; Che-Pin Tsai, C.; Abbo, K.; Goldberg, M.; Smith, T.; Martin, R.T.
Source
JACC: Heart Failure; May 2017, Vol. 5 Issue: 5 p317-326, 10p
Subject
Language
ISSN
22131779
Abstract
The objective of this clinical trial was to evaluate the long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure.